GCC Pregabalin Market Outlook

the gcc region's pregabalin market is forecast to grow significantly between 2018 and 2032 due to increasing demand for the drug. gcc countries have been able to benefit from the increased availability of the drug and there are now several manufacturers of generic pregabalin in the region. this has led to the development of a unique environment where demand for pregabalin will continue to grow over the next decade as more people become aware of its potentially beneficial effects. the use of pregabalin in the gcc countries is extensive and primarily prescribed to treat conditions such as neuropathic pain, fibromyalgia, social anxiety disorder and epilepsy. in recent years, pregabalin has also been used in combinations with other medications for the treatment of a variety of other conditions including post-traumatic stress disorder (ptsd), epilepsy and rheumatoid arthritis. in 2015, the uae was the first country in the region to approve the use of pregabalin for treating mood and anxiety disorders such as generalised anxiety disorder (gad) and panic disorder. this has been followed by approval from saudi arabia, qatar, and kuwait in subsequent years. the increasing usage of pregabalin for the treatment of various conditions is expected to drive the growth of the gcc pregabalin market. the growing recognition amongst healthcare practitioners of the benefits of pregabalin has also been a major driver of market growth in the region. moreover, the availability of generic versions of pregabalin has also been a key factor in driving the market growth in the region. the production of generic pregabalin in the gcc countries has led to an increase in demand and availability of the drug, fuelling market growth. the rapid growth of the gcc pregabalin market is expected to continue in the future, due to increasing demand and availability of the drug across the region. as awareness of the benefits of pregabalin treatment grows, so too does the demand for pregabalin across the gcc. this, coupled with continued investment in the production of generic pregabalin in the gcc region, should lead to a further surge in demand for the drug in the years to come.